 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
||||
| about advanced cancer therapeutics | |||||
Advanced Cancer Therapeutics (ACT) is leading innovation
within the biotechnology industry. Founded in January 2007,
the company is focused on the discovery and early
development of novel cancer therapeutics as well as selection
for partnership, commercialization and manufacture of the
most promising discoveries. Utilizing its groundbreaking business
arrangement with the James
Graham Brown Cancer Center and the University of Louisville Research
Foundation, ACT will establish exclusive rights to specific
novel therapeutics and fast-track these leading edge discoveries
to the pharmaceutical
industry, and ultimately the patients who need them. |
|||||
| recent news | |||||
Advanced Cancer Therapeutics Awarded Phase I SBIR Grant to Develop Anti-Cancer Drug for Novel Cancer Metabolism Target October 11, 2012 click here U.S. Granted Patent
8,088,385 B2 Strengthens Advanced Cancer Therapeutics’ Anti-Cancer
Product Portfolio April
3,
2012 click
here |
|||||
|
|||||
 |
 |
